Ryman Healthcare enjoyed its best week in almost two years.
Acquisition adds 425 staff, bringing global head count to some 1100.
Equity raising may not happen in Q1 as international travel remains uncertain.
Move will save about $8m a year, company says.
Chinese folk cure gets the lab treatment in new clinical trial.
Craigs Investment Partners private wealth research head Mark Lister on the week ahead.
No other M&A possibility had the same cost synergies, says Grant Webster.
Tourism Holdings will gain foreign-exempt listing for ASX for the deal.
Ebos says $1.3b raised for the deal will allow for further acquisitions.
Solagri Energy attracts an Australian funder after PledgeMe campaign failed.
